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Tables:  Abstract 
   Understanding the molecular details of the sequence of events in multistep 
evolutionary pathways can reveal the extent to which natural selection exploits regulatory 
mutations affecting expression, amino acid replacements affecting the active site, amino 
acid replacements affecting protein folding or stability, or variations affecting gene copy 
number. In experimentally exploring the adaptive landscape of the evolution of resistance 
to β-lactam antibiotics in enteric bacteria, we noted that a regulatory mutation that 
increases β-lactamase expression by about twofold has a very strong tendency to be fixed 
at or near the end of the evolutionary pathway. This pattern contrasts with previous 
experiments selecting for the utilization of novel substrates, in which regulatory 
mutations that increase expression are often fixed early in the process. To understand the 
basis of the difference, we carried out experiments in which the expression of β-
lactamase was under the control of a tunable arabinose promoter. We find that the fitness 
effect of an increase in gene expression is highly dependent on the catalytic activity of 
the coding sequence. An increase in expression of an inefficient enzyme has a negligible 
effect on drug resistance, however the effect of an increase in expression of an efficient 
enzyme is very large. The contrast in the temporal incorporation of regulatory mutants 
between antibiotic resistance and the utilization of novel substrates is related to the nature 
of the function that relates enzyme activity to fitness. A mathematical model of β-lactam 
resistance is examined in detail, and shown to be consistent with the observed results. 
 
 
Introduction Much discussion has focused on the relative role of structural versus regulatory 
mutations in the evolution of novel phenotypes. Structural changes include amino acid 
replacements (e.g., Clark et al. 2003, Hoekstra et al. 2006), and regulatory mutations 
include those that alter gene expression in cis or in trans (e.g., Olds and Sibley 2003, 
Shapiro et al. 2004, 2006, Tishkoff et al. 2007, Brown et al. 2008). Various perspectives 
are summarized in Carroll (2000, 2005a, 2005b), Wray (2007), Hoekstra and Coyne 
(2007), and Lynch and Wagner (2008). 
In this paper, we take a different tack. We consider the evolution of metabolic 
capabilities to which both structural and regulatory mutations are likely to contribute. We 
ask why it is that, in some systems, regulatory mutations are incorporated early in the 
process; whereas, in other systems, regulatory mutations are incorporated late. 
Extensive previous research has observed that regulatory mutations often precede 
structural ones in enzyme evolution (Mortlock et al. 1965, Wu et al. 1968, Hegeman and 
Rosenberg 1970, Hall and Hauer 1993, among others). In these situations, existing 
enzymes often catabolize novel substrates to some extent, but they require constitutive 
regulatory mutations in order allow sufficient expression to enable growth. Similarly, 
cryptic genes for the metabolism of certain substrates reside unexpressed in microbial 
genomes until mutationally activated by promoter mutations (Hall et al. 1983, Hall 
1998). As the initial substitution in an adaptive landscape is predicted to account for 
~30% of the total fitness increase (Orr 2002), these observations suggest that regulatory 
mutations play a key role in enzyme evolution. 
  “Regulation first” has some notable exceptions, however. For example, Weinreich 
et al. (2006) found that structural mutations usually precede regulatory mutations in the evolution of the TEM β–lactamase in E. coli. In the adaptive landscape connecting the 
wildtype TEM allele of low resistance to a quintuple mutant of high resistance, 
Weinreich et al. (2006) showed that a particular regulatory mutation denoted g4205a has 
a 75% chance of being the final mutation fixed. Similarly, studies on an evolved β–
galactosidase enzyme derived from the E. coli gene ebg have shown that this enzyme 
requires an initial structural mutation in order to facilitate growth on its substrate (Hartl & 
Hall 1974, Hall & Hartl 1974, Hall 1990). 
  In this paper, we show how temporal constraints on the incorporation of 
regulatory mutations are associated with the catalytic activity of the genes involved, and 
with the differing relationships between enzyme activity and fitness for metabolic and 
antibiotic-resistance enzymes. By means of studies of resistance to the β–lactam 
antibiotic cefotaxime in strains of E. coli containing the TEM β–lactamase, we 
empirically demonstrate the importance of structural mutations incorporated early in the 
evolutionary pathway of drug resistance. We also show that the temporal ordering of 
structural versus regulatory mutations in evolution depends on the mapping of enzyme 
activity onto fitness. Results 
  To sharpen the discussion, Figure 1 depicts three contrasting functions relating 
fitness to enzyme activity. The concave function (dashed line) depicts a relationship 
common for many metabolic enzymes, and the mapping is appropriate when metabolic 
flux serves as a proxy for fitness (Hartl et al. 1985, Dykhuizen et al. 1987). The convex 
function (dotted line) is common to enzyme-mediated antibiotic resistance. While this 
specific model has been used to successfully predict β–lactam resistance in several 
bacterial species (Zimmerman and Rosselet 1977, Nikaido and Normark 1987, Lakaye et 
al. 1999), its implications for the temporal incorporation of structural versus regulatory 
mutations has not been explored. 
  In the present studies, we constructed all combinations of three TEM β–lactamase 
mutations associated with increased resistance and placed them under the control of an 
inducible and titratable promoter derived from the arabinose operon (Materials and 
Methods). The rationale is that β–lactam resistance is affected by both structural 
mutations via changes in apparent affinity (kcat/KM) and by regulatory mutations mediated 
by changes in promoter sequences altering gene expression and therefore enzyme 
concentration (Zimmerman and Rosselet 1977). For each of the eight TEM β–lactamase 
alleles, we measured resistance across a range of expression levels (Material and 
Methods). Resistance was assayed as the minimal inhibitory concentration (MIC), the 
smallest concentration of cefotaxime that completely inhibits growth. For the kinetic 
parameters of these enzymes toward cefotaxime, we used previously published data 
(Wang et al. 2002).   The key discovery was that the effect of increased expression on drug resistance 
was highly dependent on the TEM structural gene. Most striking, alleles that contain the 
mutation Gly238Ser (G238S) result in large increases in resistance with increased 
expression, whereas alleles retaining the ancestral Gly at position 238 show no more than 
a twofold increase in resistance across a more than 100-fold increase in transcription 
(Supplementary Figure S1). While the sequence-dependent effect of increasing gene 
expression is most dramatic for the mutation G238S, the mutations Glu104Lys (E104K) 
and Met182Thr (M182T) also show modest effects (Supplementary Figure S2).  
To quantify the effect of structural mutations on the fitness effects of increased 
expression, we developed a generalized linear model (Materials and Methods) of 
antibiotic resistance (MIC) as a function of both coding sequence and expression level. 
Among the 64 MIC’s in our dataset, we find significant effects attributable to the 
independent contribution of each individual mutation (G238S, E104K, M182T) as well as 
expression level (F test, P-values: G238S = 2.2 × 10
-16, E104K = 1.914 × 10
-12, M182T = 
0.00035, expression level = 1.548 10
-15). There is, however, a highly significant 
interaction between expression level and G238S (F test, Expression × G238S P-value = 
4.776 × 10
-6). Although interactions between regulatory and coding mutations have been 
noted previously (Stam & Laurie 1996, Weinreich et al. 2006), our experimental design 
allows a formal statistical confirmation of Expression × G238S epistasis. 
  To investigate in greater detail how inducer (arabinose) concentration corresponds 
to expression level, we measured mRNA and protein concentration for a subset of alleles 
across a range of induction levels. Alleles with different coding mutations had similar 
mRNA levels at the same level of induction (Supplementary Figure S1). However, some alleles result in different steady-state enzyme concentrations at the same concentration of 
inducer (Supplementary Figure S3, Table S4). These results are consistent with previous 
work demonstrating differences in stability among these proteins in vitro (Wang et al. 
2002). The ranges in allele-specific protein abundance we observe are also consistent 
with other observations relating mRNA level to steady-state protein abundance 
(Ghaemmaghami et al. 2003). 
  Our data on protein abundance support the hypothesis that the structural mutation 
G238S is the one principally responsible for the temporal phasing of the regulatory 
mutation g4205a in the evolution of TEM β–lactamase. Correlation analysis between 
protein abundance and resistance demonstrate that resistance is significantly correlated 
with relative TEM β-lactamase abundance for alleles containing G238S (G238S and 
M182T+G238S; Spearman’s rank correlation: P = 0.0005641). However, we find no 
such correlation for the alleles containing a G at site 238 (wild type and M182T alleles; 
Spearman’s rank correlation: P = 0.287). 
  As a final step in the analysis, we used known kinetic parameters and our 
measured protein abundances to test whether a previously described fitness function for 
TEM β-lactamase (Zimmermann and Rosselet 1977) predicted the observed relationship 
between structural mutations and expression level. Figure 3 shows that the predicted 
resistance values (solid lines) do match the observed resistance values (open circles) 
across the range of protein abundance. This result suggests that the Zimmermann-
Rosselet (1977) model is a good predictor of antibiotic resistance. Further exploration of 
the evolutionary implications of this model might yield additional insights. Discussion 
Our results explain the temporal phasing of the incorporation of the regulatory 
mutation g4205a in the evolutionary pathway of TEM β-lactamase. The most important 
constraint is the identity of the residue at amino acid site 238. There is a highly 
significant epistatic interaction between G238S and expression level. In the presence of 
wildtype Gly238, the g4205a mutation yields little or no increase in antibiotic resistance, 
whereas in the presence of G238S, the effect can be large (Weinreich et al. 2006).  
The G238S mutation has such a dramatic effect because of its impact on the β-
lactamase’s affinity for its substrate, cefotaxime. The G238S substitution alone increases 
the overall rate of hydrolysis of cefotaxime by more than 65-fold (wildtype reaction rate 
constant (kcat) = 0.636 s
-1; G238S reaction rate constant (kcat) = 41.8 s
-1 (Wang et al. 
2002). This change in reaction rate (kcat), along with a smaller decrease in the Michaelis 
constant (KM), creates a nearly 100-fold higher apparent affinity for cefotaxime 
[wildtype: kcat/KM = 2.07 x 10
3 s
-1 M
-1, G238S: kcat/KM = 1.78 x 10
5 s
-1 M
-1] (Wang et al. 
2002). 
Increased substrate affinity allows for lower concentrations of enzyme to produce 
the same in vivo activity. The Zimmerman-Rosselet (1977) model of resistance predicts, 
and our data confirm, that at the same in vivo concentrations of β-lactamase, alleles with 
G238S have increased resistance while those without it do not (Supplementary Figure S4, 
Figure 3). 
In other words, G238S alters the mapping of enzyme activity onto fitness. The 
effect is explored in Figure 4, which compares the effects of increasing substrate affinity 
in concave (top) versus convex (bottom) fitness regimes. Each line represents the effect of increasing enzyme concentration for an enzyme with a given set of kinetic parameters. 
Both sets of curves exhibit fitness plateaus, where increases in enzyme concentration 
have little or no effect on fitness. In these regions of the curves, structural mutations are 
likely to be most important because structural mutations can increase fitness by allowing 
higher activity from the same concentration of enzyme. These kinds of changes can allow 
jumps from one fitness curve to another. In this way structural mutations that alter 
substrate affinity can change the rules of the game. On the other hand, in regions of the 
curve where fitness increases steeply with activity, regulatory mutations that increase 
enzyme concentration can be strongly selected. 
  Figure 4 reconciles the contrasting tempos of when regulatory mutants are likely 
to be incorporated into evolutionary pathways. In the evolution of flux-limited metabolic 
pathways illustrated by the concave fitness curves, mutations that increase gene 
expression are likely to be incorporated early, since an increase in expression can have a 
large effect on fitness. In the evolution of antibiotic resistance, illustrated by the convex 
fitness curves, mutations that increase gene expression are likely to be incorporated later, 
since increased expression of catalytically inefficient enzymes contributed negligibly to 
fitness. Materials and Methods 
Construction of E. coli Strains 
The TEM-1 gene from the plasmid pBR322 was isolated via PCR and cloned into 
the pBAD vector with a kanamycin resistance marker using the pBAD TOPO TA 
expression kit (Invitrogen, Carlsbad, CA). Point mutations were introduced into this gene 
via site-directed mutagenesis according to the Quick-change site directed mutagenesis kit 
(Stratagene, La Jolla, CA). The entire TEM locus and pBAD promoter was then 
sequenced to verify the presence of the desired point mutations and the absence of all 
other substitutions. 
In order to ensure that we could modulate the transcript levels in individual cells, 
and not merely the population as a whole, we obtained the K12-derived cell line, 
BW27783 (Khlebnikov et al. 2001; J. Keasling, Univ. California, Berkeley) and 
transformed our pBAD plasmids bearing the TEM alleles into this strain. Previous work 
had demonstrated that the arabinose operon behaved in individual cells in an “all on” or 
“all off” fashion (Khlebnikov et al. 2001). The BW27783 cell line has the promoter of its 
araE gene replaced with a constituitive promoter, eliminating positive feedback of this 
expression system. Using the BW27783 cell line, arabinose concentrations should 
correlate to the RNA abundance of the arabinose operon-controlled TEM locus in each 
cell. 
 
Resistance Assays 
We used minimum inhibitory concentration (MIC) assays to measure resistance to 
the β-lactam antibiotic cefotaxime (Sigma-Alrich, St. Louis, MO). This method is detailed by the Clinical and Laboratory Standards Institute (Performance standards… 
2007). Briefly, two fold dilution series over an appropriate range (0.03125–1024 ug/ml) 
of cefotaxime concentrations in Mueller-Hinton broth were prepared in 96 well flat 
bottom plates. Strains were struck out on fresh Luria Broth (LB) and kanamycin (KAN; 
50 ug/ml) plates. Colonies were picked the following day and grown overnight to 
saturation in LB-KAN media containing the appropriate arabinose concentration. Ninety-
six well MIC assay plates were then inoculated with ~10
5 cells/ml in each well as 
determined by cell titre counts on LB-KAN plates. MIC values from wells inoculated 
with between 10
4 and 10
6 cells/liter were insensitive to differences in cell concentration.  
Wells inoculated with concentrations higher than 10
6 or lower than 10
4 cells/ml 
demonstrated dramatically increased and decreased MIC readings respectively and were 
not used. For each overnight culture of a given strain and arabinose concentration, MIC 
assays were done in triplicate and the median MIC was determined from these three 
values.  
 
Transcription Induction Confirmation 
Quantitative reverse transcriptase PCR (Q-rtPCR) reactions were used to confirm 
high levels of TEM allele transcription from pBAD plasmids in the presence of high 
concentrations to arabinose. Two or three biological replicates for each combination of 
strains and arabinose concentration were prepared by inoculating 1ml overnight cultures. 
After approximately 18 hours of growth, the cultures were diluted 10,000 times and 
grown to log phase (OD600 ~ 0.6). One RNA extraction per biological replicate was 
performed using the RNeasy kit (Qiagen, Valencia, CA) and treated with Turbo-DNAFree (Ambion, Austin, TX). Adding the same quantity of RNA to each reaction, we 
created cDNA from total RNA using Random Hexamer Primers and Superscript II 
(Invitrogen, Carlsbad, CA). As previous experiments had shown there to be little 
variation between cDNA reactions from the same RNA preparation, we prepared only 
one cDNA reaction per RNA sample. Quantitative PCR (QPCR) reactions using SYBR 
green (Qiagen, Valencia, CA) were used to quantify cDNA concentrations in each RNA 
sample. At least six QPCR reactions (3 experimental and 3 control) were run in parallel 
for each RNA sample. Primers for both the TEM alleles and the control tRNA gene trpT 
(EG30105) were designed to amplify with 95% or greater efficiency, calculated based on 
the standard curve for each (see Statistical Analysis below). Uninduced and induced cells 
demonstrated significantly different expression levels. The wildtype and G238S+M182T 
alleles demonstrated similar mRNA levels at the same arabinose concentrations (Figure 
S1). 
 
Protein Purification 
 
In order to quantify the TEM enzymatic concentrations in our cells at different 
arabinose concentrations, we extracted and purified four of the β-lactamase missense 
mutants (all combinations of M182T and G238S, see Table S1). Briefly, each allele was 
moved into a pBAD-based arabinose-inducible over-expression and purification vector 
(pBAD Directional TOPO expression kit, Invitogen) carrying a 28 residue C-terminal 
linker including a 6xHis tag. The alleles were constructed with a combination of DNA 
digestion with the NcoI endonuclease (New England Biolabs) and ligation (EMD Biosciences) or site-directed mutagenesis (Weinreich et al. 2006). All sequences were 
verified by DNA sequencing of purified plasmids. 
Overnight cultures were grown in Terrific Broth containing 0.1% arabinose for 
each of the missense alleles in E. coli strain LMG194 (Invitrogen). Purified β-lactamase 
was obtained from 5 ml cultures using His-select iLAP columns (Sigma-Aldrich). Purity 
of the resulting elutions was verified using SDS-PAGE. Pure protein concentrations were 
between 10-1000 µg/ml as determined by Bradford assays (Quick Start Bradford Protein 
Assay, Bio-Rad, Hercules CA). The purified proteins were stored at -80ºC in 40 mM 
NaPO4 containing 40% glycerol. Note that neither imidazole nor elution salts were 
removed from the purified proteins due to problems with protein aggregation and 
precipitation from the unstable alleles. Neither additive had a significant or systematic 
effect on kinetics assays performed in this study. 
 
Enzyme Kinetics 
 
Enzyme reaction kinetics were determined using purified protein against 
nitrocefin (NTF; Oxoid Ltd, Basingstoke, Hampshire, England; λ=486 nm, Δε=15,000 
M
-1 cm
-1, concentrations from 10-200 µM) at 25ºC in 100 mM NaPO4, pH 7 buffer 
containing 2000 µg/ml bovine serum albumin (Sigma #A3059-50G) as an enzyme 
stabilizer (Laraki et al. 1999) on a 96-well spectrophotometer (Spectramax PLUS
384 from 
Molecular Devices). Initial reaction velocities were fit to the complete Michaelis-Menten 
equation (Equation 1) using non-linear least-squares for high-performance alleles (those 
with KM’s less than half the maximum substrate concentration) or to the reduced 
Michaelis-Menten equation where S << KM using standard linear regression (Equation 2) where KM is the Michaelis constant, kcat is the general rate constant, and S is the 
concentration of substrate, E0 is the enzyme concentration and v the reaction rate (Nelson 
and Cox 2000). 
 
€ 
v =
E0 ⋅ kcat ⋅ S
KM + S
              (1) 
 
 
€ 
v = E0 ⋅
kcat
KM
⋅ S              (2) 
 
All fits had P-values < 10
–3. Presented values are the average of six replicates. Standard 
errors of the mean are less than 4% of the average value (Table S1). Individual kcat and 
KM for each allele against NTF are presented in Table S1. 
 
Protein Extractions and Enzyme Concentrations  
We quantified the enzyme concentration in four of our TEM-allele expressing 
BW27783 cell lines at six of the eight arabinose concentrations used in MIC experiments. 
For each biological replicate of an allele at a given arabinose concentration, a separate 
colony was picked into liquid LB-Kan containing the appropriate arabinose concentration 
and grown for 24 hours. Following a method similar to that for MIC assays, overnight 
liquid cultures were used to inoculate ninety-six well MIC assay plates with 200 µl of 
MH broth containing arabinose at a cell concentration of ~10
5 cells/ml. These cultures 
were grown without shaking for 24 hours. We extracted total soluble protein from the 
combined volume of eight wells (~1.5ml of cell culture) using the B-PER
® Bacterial 
Protein Extraction Reagent (Pierce, Rockford, IL) according to manufacturers 
instructions. We performed three biological replicates for each allele and arabinose 
concentration tested.   Using the kinetic parameters we calculated for individual β-lactamase alleles 
toward nitrocefin (NTF) (Table S1; see above), we used dilute concentrations of protein 
extractions in saturating concentrations (50 µM) of nitrocefin to determine enzyme 
concentration in each protein extraction. Under these conditions, the rate of color change 
of the NTF solution is equal to the maximum rate of enzymatic catalysis, referred to as 
the Vmax. For each protein extraction, we measured Vmax by measuring absorbance at 
486nm every 10 seconds for 5-10 minutes. Only protein extraction dilutions that yielded 
linear curves over the entire time course were used to measure Vmax (milliΔOD/min). We 
performed four technical replicates for each protein extraction.  
After normalizing by the amount of total soluble protein extract (µg) used 
(Bradford assay, see above), we substituted our calculated Vmax for v in the inverted 
Michaelis-Menten equation (Equation 1) to calculate the enzyme concentration in each 
protein extraction. These calculations yielded protein concentrations in the 
unconventional units of milliΔOD/60µg total soluble extract. After determining the 
protein concentration in four technical replicates for each biological replicate, we 
calculated means and standard errors across the three biological replicates (See 
Supplementary Figure S3).  
 
Statistical Analysis 
Based on the maximum-likelihood approach for reporting MIC values described 
previously (Weinreich et al. (2006), we report the median MIC of the three replicate 
assays performed for each allele at each arabinose concentration.  Relative RNA expression levels based on Quantitative PCR (Q-PCR) reactions of 
cDNA created from total RNA extractions of wildtype and G238S+M182T alleles at 0% 
and 10
-2% arabinose were statistically analyzed using the following modified ΔCT 
approach. Briefly, Q-PCR reactions produced raw CT values for TEM β-lactamase and 
trpT tRNA for each cDNA sample. The replicate CT values for the trpT gene for each c-
DNA sample were averaged. This control CT value was then subtracted from each 
replicate CT value for β-lactamase to yield ΔCT. A nested analysis of variance revealed 
much greater variation in ΔCT values among biological replicate than within them. We 
averaged the replicate ΔCT values obtained from each biological replicate (cDNA 
preparation). Heteroscedasticity t-tests were used to test for the homogeneity among 
mean ΔCT values. Analysis of variance calculations and t-tests were carried out in R 
(version 2.5.0; www.R-project.org) and additional t-tests were carried out using in 
Microsoft Excel 2004 for Mac (version 11.3.7). 
Relative RNA expression levels reported in Figure S1 were calculated as follows. 
Following typical quantitative-PCR methodology involving a standard curve, a genomic 
DNA extraction from cells harboring a TEM-1 containing plasmid (pBR322) was used to 
create a 10 fold DNA dilution series over 6 orders of magnitude. CT values from these 
samples for each primer set were then plotted on a log-log scale against their relative 
concentrations. Using the best-fit line determined by these points, we used the mean 
absolute CT value for each cDNA to determine the relative concentration of cDNA of 
either TEM β-lactamase or trpT for each biological replicate. We normalized the TEM β-
lactamase transcription levels by dividing by the trpT transcription levels calculated for 
each cDNA. The calculated normalized relative quantities of TEM β-lactamase were then averaged for each genotype by arabinose combination and plotted as mean relative RNA 
concentrations in Figure S1. The error bars in Figure S1 represent the standard error 
among the normalized relative quantities calculated for each biological replicate. 
We constructed a generalized linear model (GLM, function glm() in R, ver. 2.2.1, 
The R Foundation for Statistical Computing) to analyze our MIC data. We modeled MIC 
as a function of the presence or absence of the three mutations (G238S, E104K, M182T) 
and expression level as determined by inducer concentration. For our GLM analysis, we 
gave each median MIC value in our data set an ordinal number where 1 corresponded to 
the lowest expression level (growth in 0% arabinose) and 8 corresponded to the highest 
expression level (growth in 10
-1% arabinose). As our MIC measurements represent 
quantized values and appeared underdispersed as a Poisson distribution, we used a quasi-
Poisson error distribution. To construct the final model, we first ordered the main terms 
according to decreasing significance in a model with only single terms and no 
interactions. We then included all interaction terms and removed those that F tests 
revealed did not significantly contribute to the MIC variance observed. The final model 
(MIC ~ G238S + Exp + E104K + M182T + G238S : Exp) included only significant 
terms. 
 
MIC Predictions 
We used a model first developed by Zimmerman and Rosselet (1977) and 
expanded upon by Nikaido and Normark (1987) to predict MIC values in our 
experiments (see also Lakaye et al. 1999). Combining Fick’s first law of diffusion and the Michaelis-Menten equation, Zimmerman and Rosselet (1977) derive the following 
equation for MIC: 
€ 
MIC = Cinh +
Vmax ⋅Cinh
P⋅ A KM + Cinh ( )
            (3) 
where Cinh is the periplamic concentration of β-lactam required to inactivate sufficient 
numbers of PBPs to inhibit growth, Vmax is the rate of β-lactamase mediated hydrolysis of 
β-lactam, P is the permeability coefficient for the specific β-lactam across the outer 
bacterial membrane (1.8 x 10
-5 cm s
-1 for cefotaxime in E. coli), A is the area of 
membrane per unit of cells (132 cm
2 mg
-1 for E. coli), and KM is the Michaelis constant 
for β-lactamase. 
  Substituting the relationship of Vmax = kcat*[E] (Nelson and Cox 2000) into 
equation (3), we rewrite equation 3 as: 
€ 
MIC = Cinh +
kcat ⋅[E]⋅Cinh
P⋅ A KM + Cinh ( )
            (4) 
where kcat is the overall rate constant of the β-lactamase catalyzed β-lactam hydrolysis 
and [E] is the periplasmic concentration β-lactamase. We inferred the Vmax against 
cefotaxime (nmol β-lactam hydrolysed per sec per mg dry weight) that Nikaido and 
Normark (1987) calculated for cells expressing TEM β-lactamase (contained on plasmid 
JF701(R471a)) based on equation (3). Based on their reported kcat for JF701-encoded 
TEM, we calculate [E] in Nikaido and Normark (1987)’s experiments to be 0.2508 nmol 
β-lactam hydrolysed per mg dry weight. To obtain a biologically realistic range of 
relative enzyme concentrations, we used Nikaido and Normark (1987)’s [E] to anchor the 
range of relative expression values over which we used equation (4) to predict MIC for 
each allele.   We used the previously reported kcat and KM against cefotaxime of four TEM 
alleles with E at site 104 (Wang et al. 2002) along with equation (4) to predict MIC 
values for each allele over a range of enzyme concentrations (see Figure 4). The absolute 
enzyme concentrations we measured for each allele were not readily comparable with the 
enzyme concentration from Nikaido and Normark (1987) (see units of each metric 
above). Instead, we normalized each value of enzymatic concentration in our experiments 
by dividing by the lowest enzyme concentration we observed (G238S with no arabinose). 
This procedure yielded an overall enzymatic expression range of nearly four orders of 
magnitude with each allele spanning only a part of this range (see Figure 4). Setting the 
lowest observed enzymatic concentration as 1000-fold lower than the concentration 
observed by Nikaido and Normark (1987), we predicted MIC values for each allele 
across its observed relative enzyme concentration (Figure 4, solid lines in each quadrant). 
For comparison, we then plotted the observed MICs for each allele against their 
corresponding enzyme concentration (Figure 4, points in each quadrant). Additionally, 
supplementary Figure S4 depicts MIC prediction for each allele across their entire 
collective expression range. 
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 Figure Legends 
 
Figure 1. Contrasting functions that map enzyme activity onto fitness. The dashed line 
(top) indicates a concave relationship typical for an enzyme in a metabolic pathway. The 
dotted line (bottom) indicates a convex relationship of the sort predicted for enzyme-
mediated antibiotic resistance. The solid line indicates a linear relationship. 
 
Figure 2. Resistance (MIC) versus expression level (arabinose induction) relationships 
for eight protein-coding alleles. Left panel depicts alleles without glycine at site 238 
(Solid line = wild type, dashed line = M182T, dotted line = E104K, dash-dot line = 
M182T + E104K). Right panel depicts alleles with serine at site 238 (Solid line = G238S, 
dashed line = G238S + M182T, dotted line = G238S + E104K, dash-dot line = G238S + 
M182T + E104K). MIC values are log2 transformed while % arabinose values are log10 
transformed.  
 
Figure 3. Comparison of predicted MIC values (solid lines) and observed data (open 
circles) for four alleles as a function of relative enzyme concentrations ([E]). Relative 
enzyme concentrations for G238S were adjusted to correct for unusual sensitivity to 
protein extraction procedures. See Supplementary Figure S4 for MIC predictions for each 
allele over the entire theoretical range of expression. 
 
Figure 4. These curves illustrate the relative importance of regulatory versus structural 
mutations in enzyme evolution under concave (top) and convex (bottom) fitness mappings. Arrows and labels (e.g., “5x”) indicate jumps between curves corresponding to 
enzymes with increased substrate affinity.  
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Supplementary Figure S1. Relative expression level of two genotypes at two arabinose 
concentrations based on TEM !-lactamase RNA concentration. While expression levels 
at 0% arabinose and 10-2% arabinose are significantly different for both genotypes 
(heteroscedastic t-test of two samples: Bla-0: p=0.02, Bla-3: p=0.02), expression levels 
for the two genotypes at the same arabinose concentration are not significantly different 
(heteroscedastic t-test of two samples: 0%: p=0.19, Bla-3: p=0.22). Statistical analyses 
based on mean !CT values across biological replicates (see Materials and Methods).  
 
 Supplementary Figure S2. Average effect of mutations at amino acid sites 238, 104 and 
182. The solid line in each graph represents the average MIC for the four alleles with the 
amino acid at the site indicated on the graph. Averages from alleles with wild type amino 
acids at the indicated site are represented on the left while averages from alleles with 
mutated residues are depicted on the right. Thin dashed lines above and below solid lines 
indicate the maximum and minimum median MIC value for the 4 alleles averaged at a 
given arabinose concentration. MIC values are log2 transformed while % arabinose 
values are log10 transformed.  
 
Supplementary Figure S3. Relative β-lactamase concentration as a function of arabinose 
concentration for four alleles. Values were relativized by dividing each absolute 
expression value by the lowest observed absolute expression value (G238S, 0% 
arabinose). Points represent the mean of three independent biological replicates. Error 
bars represent standard error across of biological replicates. To compensate for unusual 
sensitivity to protein extraction procedures, relative G238S values were multiplied by the 
average relative expression level of the other three alleles in the absense of arabinose. 
Solid line = wild type; dashed line = G238S; dotted line = M182T; dash-dot line = G238S 
+ M182T. Complete data set presented in Table S4.  
Supplementary Figure S4. MIC predictions for four alleles over the entire expression 
range. Solid line = wild type; dashed line = G238S; dotted line = M182T; dash-dot line = 
G238S + M182T.  
 
 
Supplementary Figure S5. The effect of structural changes versus regulatory changes in 
enzyme activity on fitness in two different fitness regimes. Dashed lines describe 
enzymes under a concave fitness-mapping regime while dotted lines describe enzymes 
under under a convex fitness-mapping regime. Arrows indicate changes in an enzyme’s 
kinetic parameters (kcat/KM) within a fitness regime. While regulatory changes move an 
organism along a given curve, structural changes alter the kinetic parameters and change 
the curve upon which the organism lies. 
 
 Supplementary Table S1. TEM β-lactamase alleles and their corresponding Michaelis-Menten and rate constants toward nitrocefin 
(see Materials and Methods). A “plus” sign indicates the presence of the mutation listed above the column. 
   
 
Allele
a  E104K  M182T  G238S  KM (µM)  sd
b (KM)  kcat (1/sec)  sd (kcat) 
 
 
0  -  -  -  50.2  2.7  12800  561 
 
1  -  -  +  11.5  0.8  737  48.8   
 
2  -  +  -  51.9  4.3  16700  982 
 
3  -  +  +  11.4  3.5  203  13.6 
 
4  +  -  -  nd
c    nd 
 
5  +  -  +  nd    nd 
 
6  +  +  -  nd    nd 
 
7  +  +  +  nd    nd 
 
 
a For ease of reference, allele designations used in this table are repeated throughout the Supplementary Information. 
b sd: Standard deviation of the value indicated. 
c nd: Not determined. 
 Supplementary Table S2. Median MIC values (µg/ml) for eight alleles at eight arabinose concentrations.  
 
 
  Arabinose induction 
 
 
Allele  0%  10
-5%  10
-4%  5 x 10
-4%  10
-3%  5 x 10
-3%  10
-2%  10
-1% 
 
 
0  0.03  0.03  0.06  0.06  0.06  0.06  0.06  0.06 
 
1  0.03  0.03  0.03  0.13  0.5  0.5  0.5  1 
 
2  0.06  0.06  0.06  0.03  0.06  0.06  0.06  0.03 
 
3  0.03  0.06  0.06  0.25  0.5  1  1  2 
 
4  0.06  0.06  0.06  0.03  0.13  0.13  0.13  0.13 
 
5  0.13  0.13  0.13  1  2  4  4  4 
 
6  0.13  0.06  0.13  0.13  0.13  0.25  0.13  0.13 
 
7  0.25  0.125  0.5  8  16  16  16  32 
 Supplementary Table S3. Complete MIC data set. 
 
 
Allele  [Arabinose]    Replicate MIC (µg/ml) values 
 
 
0  0%    0.03  0.03  0.03 
  10
-5%    0.03  0.03  0.03 
  10
-4%    0.06  0.06  0.06 
  5 x 10
-4%    0.06  0.06  0.06 
  10
-3%    0.06  0.06  0.06 
  5 x 10
-3%    0.06  0.06  0.03 
  10
-2%    0.06  0.06  0.06 
  10
-1%    0.06  0.06  0.06 
 
1  0%    0.03  0.03  0.03 
  10
-5%    0.03  0.03  0.03 
  10
-4%    0.03  0.03  0.03 
  5 x 10
-4%    0.25  0.13  0.13 
  10
-3%    0.5  0.5  0.5 
  5 x 10
-3%    0.25  0.5  0.5 
  10
-2%    0.5  0.5  0.5 
  10
-1%    1  1  1 
 
2  0%    0.06  0.06  0.06 
  10
-5%    0.06  0.06  0.06 
  10
-4%    0.06  0.06  0.06 
  5 x 10
-4%    0.03  0.03  0.03 
  10
-3%    0.06  0.06  0.06 
  5 x 10
-3%    0.06  0.06  0.06 
  10
-2%    0.06  0.06  0.03 
  10
-1%    0.06  0.03  0.03 
 
3  0%    0.03  0.03  0.06 
  10
-5%    0.06  0.06  0.06 
  10
-4%    0.06  0.06  0.06 
  5 x 10
-4%    0.25  0.125  0.25 
  10
-3%    0.5  0.5  0.5 
  5 x 10
-3%    1  2  1 
  10
-2%    1  2  1 
  10
-1%    2  4  2 Table S3 (continued).  
 
 
Allele  [Arabinose]    Replicate MIC (µg/ml) values 
 
 
4  0%    0.06  0.13  0.06 
  10
-5%    0.06  0.13  0.06 
  10
-4%    0.06  0.13  0.06 
  5 x 10
-4%    0.06  0.03  0.03 
  10
-3%    0.13  0.13  0.13 
  5 x 10
-3%    0.13  0.13  0.13 
  10
-2%    0.13  0.13  0.13 
  10
-1%    0.13  0.13  0.13 
 
5  0%    0.13  0.13  0.13 
  10
-5%    0.13  0.13  0.13 
  10
-4%    0.13  0.13  0.25 
  5 x 10
-4%    2  1  1 
  10
-3%    2  2  2 
  5 x 10
-3%    4  4  4 
  10
-2%    4  4  4 
  10
-1%    4  4  F* 
 
6  0%    0.13  0.13  0.13 
  10
-5%    0.06  0.06  0.06 
  10
-4%    0.13  0.13  0.13 
  5 x 10
-4%    0.13  0.13  0.13 
  10
-3%    0.13  0.13  0.06 
  5 x 10
-3%    0.25  0.25  0.25 
  10
-2%    0.13  0.13  0.13 
  10
-1%    0.13  0.13  0.13 
 
7  0%    0.25  0.13  0.25 
  10
-5%    0.13  0.13  0.25 
  10
-4%    0.25  0.5  0.5 
  5 x 10
-4%    8  8  8 
  10
-3%    32  16  8 
  5 x 10
-3%    16  16  16 
  10
-2%    16  16  16 
  10
-1%    64  32  32 
 
* indicates failed MIC test. 
 Supplementary Table S4. Mean β-lactamase concentration in soluble protein extracts (milliΔOD/(60mg soluble protein extract)) as a 
function of arabnose induction level.  Data used to create Figure 4.  Standard error for each value is indicated in the line immediately 
below the averages (denoted SE). 
 
 
  Arabinose induction 
 
 
Allele  0%  10
-5%  10
-4%  10
-3%  10
-2%  10
-1% 
 
 
0  9.5e-6  5.0e-5  6.1e-5  2.0e-4  9.8e-4  1.2e-3 
 
SE  3.3e-6  3.3e-5  6.3e-6  3.8e-5  2.5e-4  6.0e-4 
 
 
1  1.6e-6  2.5e-6  5.5e-6  1.9e-5  2.1e-5  2.1e-5 
 
SE  6.5e-7  1.2e-6  3.1e-6  7.7e-7  8.1e-6  1.5e-5 
 
 
2  5.6e-5  7.4e-5  2.0e-4  5.3e-4  1.5e-3  4.5e-4 
 
SE  7.2e-6  3.0e-5  5.7e-5  1.1e-4  2.6e-4  1.9e-4 
 
 
3  7.3e-5  2.0e-4  1.5e-3  2.4e-3  1.7e-3  9.6e-3 
 
SE  2.2e-5  1.2e-4  1.3e-3  8.5e-5  4.9e-4  4.0e-3 
 